CN104829541B - 高选择性及高纯度制备吗啉硝唑的方法 - Google Patents
高选择性及高纯度制备吗啉硝唑的方法 Download PDFInfo
- Publication number
- CN104829541B CN104829541B CN201510225004.4A CN201510225004A CN104829541B CN 104829541 B CN104829541 B CN 104829541B CN 201510225004 A CN201510225004 A CN 201510225004A CN 104829541 B CN104829541 B CN 104829541B
- Authority
- CN
- China
- Prior art keywords
- preparation
- compound
- formula
- acid
- nitre azoles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- YNAVUWVOSKDBBP-UHFFFAOYSA-N C1NCCOC1 Chemical compound C1NCCOC1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- WXXATWPCYJAJIY-UHFFFAOYSA-N CCC(C[n]1c([N+]([O-])=O)cnc1C)O Chemical compound CCC(C[n]1c([N+]([O-])=O)cnc1C)O WXXATWPCYJAJIY-UHFFFAOYSA-N 0.000 description 1
- IXNOXSYSIQULDJ-UHFFFAOYSA-N Cc([n]1CC(CCO)N2CCOCC2)ncc1[N+]([O-])=O Chemical compound Cc([n]1CC(CCO)N2CCOCC2)ncc1[N+]([O-])=O IXNOXSYSIQULDJ-UHFFFAOYSA-N 0.000 description 1
- QGSCFUPHTWEHFD-UHFFFAOYSA-N Cc([n]1CC(CCl)N2CCOCC2)ncc1[N+]([O-])=O Chemical compound Cc([n]1CC(CCl)N2CCOCC2)ncc1[N+]([O-])=O QGSCFUPHTWEHFD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/95—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510225004.4A CN104829541B (zh) | 2015-05-05 | 2015-05-05 | 高选择性及高纯度制备吗啉硝唑的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510225004.4A CN104829541B (zh) | 2015-05-05 | 2015-05-05 | 高选择性及高纯度制备吗啉硝唑的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104829541A CN104829541A (zh) | 2015-08-12 |
CN104829541B true CN104829541B (zh) | 2017-06-30 |
Family
ID=53807784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510225004.4A Active CN104829541B (zh) | 2015-05-05 | 2015-05-05 | 高选择性及高纯度制备吗啉硝唑的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104829541B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104628651B (zh) * | 2013-11-06 | 2018-07-24 | 江苏豪森药业集团有限公司 | 吗啉硝唑异构体及其制备方法 |
CN106699669A (zh) * | 2015-11-18 | 2017-05-24 | 陕西合成药业股份有限公司 | 一种左旋吗啉硝唑晶型及其制备方法和药用组合物的用途 |
CN111973569A (zh) * | 2019-05-21 | 2020-11-24 | 江苏豪森药业集团有限公司 | 含有硝基咪唑类衍生物的药物组合物及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100344626C (zh) * | 2003-10-08 | 2007-10-24 | 连云港恒邦医药科技有限公司 | α-(吗啉-1-基)甲基-2-甲基-5-硝基咪唑-1-乙醇用于制备抗厌氧菌药物的用途 |
WO2006058457A1 (fr) * | 2004-11-30 | 2006-06-08 | Lianyungang Hengbang Pharmaceutical Co. Ltd. | DÉRIVÉS DE 2-MÉTHYL-5-NITROIMIDAZOL-1-ÉTHANOL α-SUBSTITUÉS |
CN100427094C (zh) * | 2005-12-13 | 2008-10-22 | 江苏豪森药业股份有限公司 | α-(吗啉-1-基)甲基-2-甲基-5-硝基咪唑-1-乙醇在制备抗滴虫、抗阿米巴原虫药物的用途 |
EP1829873A1 (en) * | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | Pyrrazole derivatives as sigma receptors antagonists |
CN102199147A (zh) * | 2011-03-19 | 2011-09-28 | 陕西合成药业有限公司 | 用于治疗的硝基咪唑衍生物 |
-
2015
- 2015-05-05 CN CN201510225004.4A patent/CN104829541B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104829541A (zh) | 2015-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104829541B (zh) | 高选择性及高纯度制备吗啉硝唑的方法 | |
CN104945299B (zh) | 一种维格列汀的高效合成方法 | |
CN101538255B (zh) | 2-甲氧基亚氨基2-呋喃乙酸胺的制备方法 | |
CN106699570B (zh) | (2-氯-5-碘苯基)(4-氟苯基)甲酮的合成方法 | |
CN104829602A (zh) | 一种依匹哌唑的制备方法 | |
CN109438405A (zh) | 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法 | |
CN106588831A (zh) | 一种呋喃酮类化合物的制备方法 | |
CN107325082B (zh) | 一种高纯度阿法替尼的制备方法 | |
WO2020000832A1 (zh) | 一种奧替拉西钾的合成方法 | |
CN105481856B (zh) | 一种帕利哌酮的制备方法 | |
CN106588740A (zh) | 一种己酸衍生物的制备方法 | |
KR20060120036A (ko) | 페남 결정 및 그 제조법 | |
CN108358900A (zh) | 一种阿法替尼及其马来酸盐的制备方法 | |
CN108456198B (zh) | 维拉佐酮或其盐酸盐的制备方法 | |
CN109160908A (zh) | 一种2-甲氧亚胺基-2-呋喃乙酸的合成方法 | |
CN113248439A (zh) | 一种吡唑二硫的合成方法 | |
CN103833660B (zh) | 拉莫三嗪及其中间体的制备方法 | |
EP2643308A1 (en) | Process for the preparation of taurolidine and its intermediates thereof | |
CN107129472B (zh) | 一种制备乙酰唑胺中间体的工艺 | |
CN106749007B (zh) | 一种制备7-羟基-2-喹诺酮的方法 | |
CN112110854A (zh) | 一种吉美嘧啶中间体的制备方法 | |
CN108727410A (zh) | 一种羟甲基头孢妥仑匹酯的制备方法 | |
KR20140140398A (ko) | 고순도 미르타자핀의 제조방법 | |
KR100911720B1 (ko) | 결정형 염산 사포그릴레이트의 제조방법 | |
CN108727418A (zh) | 一种头孢妥仑匹酯二聚体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant |